Aristo Bio-Tech and Lifescience Ltd. makes a strong debut on the bourses with scrip got listed at Rs 80.00 on the Bombay Stock Exchange, a 11.11 per cent premium to its issue price of Rs 72.00. On the National Stock Exchange, the stock was listed at Rs 80.00.

The company, which raised 0.18 Cr from initial public offering, was subscribed 206.94 times, receiving bids for 3,751.41 lakhs shares against the total issue size of 18.13 lakhs shares.

The company, listed under ST Group Securities post its IPO, opened for subscription from Jan 16 to Jan 19.

Following a strong opening, the scrip touched an intraday high of Rs [BSEHighPrice] and a low of Rs [NSEHighPrice], before closing the session [UpDown] by [ChangePer] per cent to its listing price at Rs [ClosingPriceBSE] on the NSE.

The company anticipates using the proceeds of the issue for To Meet Working Capital Requirement General Corporate Purpose To Meet the Issue Expenses.

Beeline Capital Advisors Pvt. Ltd. as lead managers & Link Intime India Private Limited is the registrar, to the issue.

Meanwhile, the broader benchmark NSE Nifty closed trade at 17,604.35, down 287.60 points, or 1.60 per cent.